BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

3DM Inc. Release: PuraMatrix Hydrogels Win International Awards For Biomaterial Nanotechnology And Regenerative Medicine


10/19/2005 5:10:14 PM

BOSTON, March 2 /PRNewswire/ -- 3DM, Inc. today announced that it's PuraMatrix(TM) line of synthetic hydrogels was awarded the annual Excellence in Technology Award in the field of Biomaterial Technology by Frost & Sullivan, a leading technology market research firm. In addition, 3DM co- founders Drs. Shuguang Zhang and Carlos Semino, have each received awards for outstanding contributions to the fields of materials science and cell biology by the Japanese Society for the Promotion of Science and the 2003 World Congress on Regenerative Medicine, respectively.

"PuraMatrix is beginning to prove its value across a number of applications in orthopedic medical devices, tissue engineering and stem cell regenerative medicine," stated Dr. Alan Grodzinsky, Director of the Center for Biomedical Engineering at the Massachusetts Institute of Technology (MIT), "These awards recognize the pioneering work of Drs. Zhang, Semino and others who are furthering work on these elegantly simple biomaterials."

Dr. Robert Langer, one of the world's foremost experts on biomaterials and tissue engineering and Professor of Chemical and Biomedical Engineering at MIT, emphasized "Through the impressive work of Shuguang Zhang and his colleagues, PuraMatrix is finding more and more novel uses in biology and bioengineering."

Frost & Sullivan, a leading technology market research firm, has awarded PuraMatrix its annual Excellence in Technology Award in the field of Biomaterial Technology. As detailed in their newly released Advanced in Biomaterials research report, PuraMatrix has become widely accepted by the biotechnology, pharmaceutical and medical device communities to create defined 3-D cell cultures and cell-based assays. PuraMatrix serves as a synthetic biodegradable alternative to animal-derived biomaterials such as bovine collagen. The report also details trends in medical nanofibers, biopolymers and medical device coatings.

Dr. Shuguang Zhang has been selected as a 2003-2004 Fellow from the Japanese Society for the Promotion of Science, in honor of his contributions to biomaterials and regenerative medicine. In tandem with accepting the fellowship, Dr. Zhang will present his work on PuraMatrix at the 3rd General Congress on Regenerative Medicine in Tokyo, March 25, 2004.

Dr. Carlos Semino was honored with the Paul H. Fraisse Prize for Outstanding Scientific Contribution at the 2003 World Congress on Regenerative Medicine (http://www.regmed.org/) held in Leipzig, Germany. Dr. Semino's presentation was entitled "Bioengineering Cell-Instructive Synthetic Extracellular Matrices for Tissue Engineering" and detailed his work with hepatocyte progenitor cultures in PuraMatrix.

About PuraMatrix

PuraMatrix Hydrogels may be used to create synthetic nanofiber scaffolds to encapsulate cells in 3-D, plate cells in 2-D coatings, or as microcarriers in suspension cultures. PuraMatrix has utility in medical devices and research encompassing drug discovery, tissue engineering, cell migration and invasion, neurite outgrowth, and hepatocyte functionality and toxicity. PuraMatrix was recently featured articles and papers in Nature, Nature Biotechnology, EMBO, and Tissue Engineering. Medical products companies have begun replacing bovine collagen and other animal-derived biomaterials with synthetic PuraMatrix in their production processes and end products. PuraMatrix is forward compatible with in vivo implant studies, clinical therapeutics and bioproduction cGMP requirements, and is already in use at major pharmaceutical companies, the National Institutes of Health, and leading clinical research institutions such as MDAnderson, Dana Farber Cancer Institute, and Massachusetts General Hospital.

About 3DM Inc.

3DM is a privately-held specialty biomaterials and medical device company headquartered in Cambridge, Massachusetts. The patented technology, exclusively licensed from Massachusetts Institute of Technology, was pioneered through the work and expertise of Drs. Alan Grodzinsky, Robert Langer, Alexander Rich, Carlos Semino, and Shuguang Zhang.

Contact: Zen Chu, President contact@puramatrix.com Website: http://www.puramatrix.com/

3DM, Inc.

CONTACT: Zen Chu, President, 3DM, Inc., contact@puramatrix.com



Read at BioSpace.com

3DM Inc.
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES